Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry
- PMID: 39946437
- PMCID: PMC12175941
- DOI: 10.1164/rccm.202401-0023OC
Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry
Abstract
Rationale: The impact of respiratory exacerbation on chronic obstructive pulmonary disease (COPD) is well established. The effects of respiratory exacerbations in people with cigarette smoking but normal spirometry are unknown. Objectives: To assess the association of respiratory exacerbations with lung function decline and mortality in people with normal spirometry and current or former cigarette smoking history. Methods: We analyzed data from COPDGene study participants with ⩾10 pack-years of cigarette smoking and normal spirometry at enrollment (Visit 1) defined as post-bronchodilator FEV1/FVC greater than or equal to the lower limit of normal and FEV1 greater than or equal to the lower limit of normal. We examined whether respiratory exacerbations occurring between Visit 1 and the 5-year follow-up visit (Visit 2) were associated with FEV1 decline and all-cause mortality. Measurements and Main Results: Among 2,939 participants with cigarette smoking history and normal lung function at Visit 1, each additional exacerbation between Visits 1 and 2 was associated with a 2.96 ml/yr FEV1 decline (95% confidence interval [CI], 1.81 to 4.12; P < 0.001) at Visit 2. Experiencing one or more severe exacerbations between Visits 1 and 2 was associated with 14.6 ml/yr FEV1 decline relative to those with no severe exacerbations (95% CI, 8.56 to 20.6; P < 0.001). Individuals with one or more severe exacerbations between Visits 1 and 2 had increased mortality compared with those with no severe exacerbations (17.1% vs. 9.8%; adjusted hazard ratio, 1.97; 95% CI, 1.40 to 2.77; P < 0.001). Conclusions: Respiratory exacerbations in people with cigarette smoking but normal spirometry were associated with lung function decline. Experiencing a severe respiratory exacerbation was associated with increased mortality.
Keywords: chronic obstructive pulmonary disease; death; respiratory function tests; smoking; symptom flare-up.
Comment in
-
Lung Function Decline in Smokers with Normal Spirometry: The Devastating Impact of Lung Attacks.Am J Respir Crit Care Med. 2025 Jun;211(6):891-892. doi: 10.1164/rccm.202501-0223ED. Am J Respir Crit Care Med. 2025. PMID: 40106823 Free PMC article. No abstract available.
References
-
- Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 2021;203:24–36. - PMC - PubMed
-
- Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest . 2000;117:5S–9S. - PubMed
-
- Wang Q, Bourbeau J. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology . 2005;10:334–340. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical